Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 5, 1996, Pages 923-929

  Rathbun, William B ^a   Holleschau, Ann M ^a   Cohen, Jonathan F ^b   Nagasawa, Herbert T ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acetaminophen; Cataract prevention; Cysteine; Glutathione; Naphthalene

Indexed keywords

BETA NAPHTHOFLAVONE; CYSTEINE 2 MERCAPTOETHANOL DISULFIDE; CYSTEINE DERIVATIVE; CYSTINE; CYTOCHROME P450 ISOENZYME; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCINE; METHIONINE; N ACETYL 2 MERCAPTOETHANOL CYSTEINE ETHYL ESTER DISULFIDE; NAPHTHALENE; PARACETAMOL; PHENOBARBITAL; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; ENZYME INDUCTION; GLUTATHIONE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; LENS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CATARACT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; DRUG COMBINATIONS; GLUTATHIONE; LENS, CRYSTALLINE; LIVER; MALE; MERCAPTOETHANOL; MICE; MICE, INBRED C57BL; NAPHTHALENES; ORGAN CULTURE TECHNIQUES; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0029968519     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Varma SD, Chand D, Sharma YR, Kuck JF Jr, Richards RD. Oxidative stress on lens and cataract formation: Role of light and oxygen. Curr Eye Res. 1984;3:35-37.
2. Varma SD. Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr. 1991;53:335S-345S.
3. Bhuyan KG, Bhuyan DK, Ruck JFR Jr, Kuck KD, Kern HL. Increased lipid peroxidation and altered membrane functions in Emory mouse cataract. Curr Eye Ass. 1983;2:597-606.
4. Spector A. Oxidation and cataract. In: Ciba Foundation Symposium 106. Human Cataract Formation. London: Pitman; 1984:48-64.
5. Reis W. Über die Cysteinreaktion der normalen und pathologische veränderten Linsen. Arch für Ophthalmol. 1912:80:588-598.
6. Rathbun WB. Glutathione in ocular tissues. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: Chemical, Biochemical, and Medical Aspects. Vol. III, Part B of the series Coenzymes and Cofactors. New York: John Wiley & Sons; 1989:467-510.
7. Rathbun WB, Murray DL. Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens. Exp Eye Res. 1991;53:205-212.
8. Gander JE, Sethna SS, Rathbun WB. Bovine lens γ-glutamylcysteine synthetase: Inhibition by glutathione and adenine nucleotides. Eur J Biochem. 1983;133: 635-640.
9. Harper AE. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev. 1970;50:428-558.
10. Ishii T, Bannai S, Sugita Y. Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro role of the mixed disulfide of 2-mercaptoethanol and L-cysteine. J Biol Chem. 1981;256:12387-12392.
11. Murray DL, Rathbun WB. Conditions for maximizing and inhibiting synthesis of glutathione in cultured rat lenses: An application of HPLC with radioisotope detection. Curr Eye Res. 1990;9:55-63.
12. Nagasawa HT, Cohen JF, Rathbun WB. Mixed disulfides of L-cysteine and its derivatives with 2-mercaptoethanol. Organic Preparations and Procedures International. 1996;28:in press.
13. Lubek BM, Basu PK, Wells PG. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains. Toxicol Appl Pharmacol. 1988;94:487-495.
14. Wells PG, Wilson B, Lubek BM. In vivo studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol Appl Pharmacol. 1989;99:466-473.
15. Holleschau AM, Rathbun WB, Nagasawa HT. An HPLC radiotracer method for assessing the ability of L-cysteine prodrugs to maintain glutathione levels in the cultured rat lens. Curr Eye Res. 1996;15:in press.
16. Shichi H, Gaasterland DE, Jensen NM, Nebert DW. Ah locus: Genetic differences in susceptibility to cataracts induced by acetaminophen. Science. 1978;200:539-541.
17. Xu G-T, Zigler JS, Lou MF. Establishment of a naphthalene cataract model in vitro. Exp Eye Res. 1992; 54:73-81.
18. Van Heyningen R, Piric A. The metabolism of naphthalene and its toxic effect on the eye. Biochem J. 1967;102:842-852.
19. Shichi H, Tanaka M, Jensen NM, Nebert DW. Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacology. 1980;20:229-241.
20. Hinson JA. Biochemical toxicology of acetaminophen. In: Hodgson E, Bend JR, Philpot RM, eds. Reviews in Biochemical Toxicology. Vol 2. New York: Elsevier; 1980:103-129.
21. Ishii T, Sugita Y, Bannai, S. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J Cell Physiol. 1987;133:330-336.
22. Chen C, Hirsch JG. The effects of mercaptoethanol and peritoneal macrophages on the antibody-forming capacity of non adherent mouse spleen cells in vitro. J Exp Med. 1972;136:604-617.
23. Herber-Katz E, Click RE. Immune responses in vitro: V: Role of mercaptoethanol in the mixed leukocyte reaction. Cell Immunol. 1972;5:410-418.